Bayban’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bayban's BMY Position: Q3 2026 in Review
Bayban increased its Bristol-Myers Squibb (BMY) stake by 99% in Q3 2026, buying an estimated $36K and bringing the position to 1,145 shares worth $71.4K. The position accounts for 0.05% of the portfolio, ranked #204.
Bayban first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Bayban held 1,145 shares of Bristol-Myers Squibb worth $71.4K as of Q3 2026.
- Bayban bought 570 Bristol-Myers Squibb shares in Q3 2026, an estimated $36K.
- Bristol-Myers Squibb made up 0.05% of Bayban's portfolio in Q3 2026, its #204 holding.
- Bayban first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.